Certain BlackRock Funds Announce Final Results of Tender Offers

In This Article:

NEW YORK, August 21, 2024--(BUSINESS WIRE)--The BlackRock closed-end funds (the "Funds") listed below announced today the final results of each Fund’s tender offer (each, a "Tender Offer") for up to 2.5% of its outstanding common shares (the "Shares").

The Tender Offers, which expired at 5:00 p.m. Eastern time on August 19, 2024, were oversubscribed for each Fund.

Therefore, in accordance with the terms and conditions of the Tender Offers, each Fund will purchase Shares from all tendering shareholders on a pro rata basis, after disregarding fractions, based on the number of Shares properly tendered ("Pro-Ration Factor"). The final results of the Tender Offers are provided in the table below.

Fund Name

Ticker

CUSIP

Number of

Shares

Tendered

Number of

Tendered Shares

to be Purchased

Pro-Ration

Factor

Purchase

Price*

 

BlackRock Health Sciences Term Trust

 

BMEZ

09260E105

24,040,558

2,662,856

0.11086350

$17.6204

 

BlackRock Health Sciences Trust

 

BME

09250W107

1,279,599

348,599

0.27267200

$44.4822

BlackRock Enhanced International Dividend Trust

BGY

092524107

33,752,225

2,506,796

0.07431160

$6.3014

*Equal to 98% of the Fund’s net asset value per Share as of the close of regular trading on the New York Stock Exchange on August 20, 2024 (the business day immediately following the expiration date of the Tender Offer).

Payments for Shares tendered and accepted are expected to be made within approximately five business days after the expiration date.

Questions regarding the Tender Offers may be directed to Georgeson LLC, the Information Agent for the Tender Offers, toll free at the numbers disclosed in each Fund’s Offer to Purchase.

Important Notice

This press release is for informational purposes only and shall not constitute a recommendation, an offer to purchase or a solicitation of an offer to sell any common shares of the Funds. The offer to purchase a Fund’s common shares was made only pursuant to an offer to purchase, a related letter of transmittal and other documents filed with the U.S. Securities and Exchange Commission ("SEC") as exhibits to a tender offer statement on Schedule TO. Shareholders may obtain a free copy of the offer to purchase and other documents filed with the SEC at the website maintained by the SEC at www.sec.gov or by directing such requests to the applicable Fund.

About BlackRock

BlackRock’s purpose is to help more and more people experience financial well-being. As a fiduciary to investors and a leading provider of financial technology, we help millions of people build savings that serve them throughout their lives by making investing easier and more affordable. For additional information on BlackRock, please visit www.blackrock.com/corporate